FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230752000> ?p ?o ?g. }

• W4230752000 abstract "Background Cardiovascular deaths account for the majority of deaths in kidney transplant recipients and dyslipidaemia contributes significantly to their cardiovascular disease. Statins are widely used in kidney transplant patients given their established benefits in the general population, however evidence favouring their use is lacking. Objectives To assess the benefits and harms of statin therapy on mortality and renal outcomes in kidney transplant recipients. Search methods We searched MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), and hand searched reference lists of articles and scientific proceedings. Selection criteria Randomised controlled trials (RCTs) and quasi‐RCTs comparing statins with placebo, no treatment or other statins in kidney transplant recipients. Data collection and analysis Two authors independently assessed study quality and extracted data. Statistical analyses were performed using the random effects model after testing for heterogeneity. Results were expressed as mean difference (MD) for continuous outcomes (lipid parameters) and risk ratio (RR) for dichotomous outcomes (mortality, allograft rejection, liver enzymes, occurrence of rhabdomyolysis and study withdrawal) with 95% confidence intervals (CI). Main results Sixteen studies (3229 patients) comparing statins versus placebo (15) or another statin (1) were included. Compared to placebo, statins did not decrease all‐cause mortality (14 studies: RR 1.30, 95% CI 0.54 to 3.12). Point estimates favoured statins in terms of cardiovascular mortality (13 studies: RR 0.68, 95% CI 0.46 to 1.03) and non‐fatal cardiovascular events (1 study: RR 0.70, 95% CI 0.48 to 1.01), however the results were not statistically significant. Compared to placebo, the use of statins was associated with a significantly lower end of treatment average total cholesterol (10 studies: MD ‐42.33 mg/dL (1.26 mmol/L), 95% CI ‐53.02 to ‐31.64), LDL cholesterol (10 studies: MD ‐46.15 mg/dL (1.19 mmol/L), 95% CI ‐55.97 to ‐36.33) and triglycerides (10 studies: MD ‐25.46 mg/dL (0.26 mmol/L), 95% CI ‐33.95 to 16.9). There was no significant difference in the risk of acute rejection (5 studies: RR 0.61; 95% C.I.0.32 to 1.16.) No data on chronic rejection was available and no major toxicity was noted. Authors' conclusions Statins significantly reduced hyperlipidaemia and tended to reduce cardiovascular events in kidney transplant recipients, but no effect has yet been demonstrated for mortality outcomes. Most of the data was derived from one large long‐term study. Considering the significant impact of statins on all‐cause and cardiovascular mortality in the general and predialysis populations, more studies are needed in kidney transplant patients." @default.
• W4230752000 created "2022-05-11" @default.
• W4230752000 creator A5027520502 @default.
• W4230752000 creator A5035786059 @default.
• W4230752000 creator A5038938109 @default.
• W4230752000 creator A5043394711 @default.
• W4230752000 creator A5046112080 @default.
• W4230752000 creator A5088788555 @default.
• W4230752000 date "2009-04-15" @default.
• W4230752000 modified "2023-09-25" @default.
• W4230752000 title "HMG CoA reductase inhibitors (statins) for kidney transplant recipients" @default.
• W4230752000 cites W1500963439 @default.
• W4230752000 cites W1502524639 @default.
• W4230752000 cites W1573777214 @default.
• W4230752000 cites W1891715432 @default.
• W4230752000 cites W1939259427 @default.
• W4230752000 cites W1960912206 @default.
• W4230752000 cites W1975705705 @default.
• W4230752000 cites W1979086297 @default.
• W4230752000 cites W1994930409 @default.
• W4230752000 cites W1999187183 @default.
• W4230752000 cites W2001285551 @default.
• W4230752000 cites W2004330500 @default.
• W4230752000 cites W2008797334 @default.
• W4230752000 cites W2011010559 @default.
• W4230752000 cites W2011103783 @default.
• W4230752000 cites W2011377445 @default.
• W4230752000 cites W2012821845 @default.
• W4230752000 cites W2013467357 @default.
• W4230752000 cites W2013755756 @default.
• W4230752000 cites W2013800720 @default.
• W4230752000 cites W2016265356 @default.
• W4230752000 cites W2024595878 @default.
• W4230752000 cites W2028056878 @default.
• W4230752000 cites W2031185570 @default.
• W4230752000 cites W2033471268 @default.
• W4230752000 cites W2035811858 @default.
• W4230752000 cites W2037198165 @default.
• W4230752000 cites W2040904160 @default.
• W4230752000 cites W2052989238 @default.
• W4230752000 cites W2060774684 @default.
• W4230752000 cites W2061190448 @default.
• W4230752000 cites W2064649898 @default.
• W4230752000 cites W2067677131 @default.
• W4230752000 cites W2069617483 @default.
• W4230752000 cites W2084126045 @default.
• W4230752000 cites W2088865411 @default.
• W4230752000 cites W2092674082 @default.
• W4230752000 cites W2093758594 @default.
• W4230752000 cites W2107943520 @default.
• W4230752000 cites W2109355182 @default.
• W4230752000 cites W2111593137 @default.
• W4230752000 cites W2112009673 @default.
• W4230752000 cites W2125342975 @default.
• W4230752000 cites W2127668399 @default.
• W4230752000 cites W2132802195 @default.
• W4230752000 cites W2137914533 @default.
• W4230752000 cites W2138464181 @default.
• W4230752000 cites W2141137365 @default.
• W4230752000 cites W2155598961 @default.
• W4230752000 cites W2156880046 @default.
• W4230752000 cites W2162050086 @default.
• W4230752000 cites W2166121680 @default.
• W4230752000 cites W2284948208 @default.
• W4230752000 cites W2325308994 @default.
• W4230752000 cites W2327533441 @default.
• W4230752000 cites W2331937676 @default.
• W4230752000 cites W4239339499 @default.
• W4230752000 cites W4249377962 @default.
• W4230752000 doi "https://doi.org/10.1002/14651858.cd005019.pub3" @default.
• W4230752000 hasPublicationYear "2009" @default.
• W4230752000 type Work @default.
• W4230752000 citedByCount "15" @default.
• W4230752000 countsByYear W42307520002012 @default.
• W4230752000 countsByYear W42307520002013 @default.
• W4230752000 countsByYear W42307520002014 @default.
• W4230752000 countsByYear W42307520002019 @default.
• W4230752000 countsByYear W42307520002020 @default.
• W4230752000 crossrefType "reference-entry" @default.
• W4230752000 hasAuthorship W4230752000A5027520502 @default.
• W4230752000 hasAuthorship W4230752000A5035786059 @default.
• W4230752000 hasAuthorship W4230752000A5038938109 @default.
• W4230752000 hasAuthorship W4230752000A5043394711 @default.
• W4230752000 hasAuthorship W4230752000A5046112080 @default.
• W4230752000 hasAuthorship W4230752000A5088788555 @default.
• W4230752000 hasConcept C126322002 @default.
• W4230752000 hasConcept C142724271 @default.
• W4230752000 hasConcept C168563851 @default.
• W4230752000 hasConcept C204787440 @default.
• W4230752000 hasConcept C27081682 @default.
• W4230752000 hasConcept C2776839432 @default.
• W4230752000 hasConcept C2777482532 @default.
• W4230752000 hasConcept C2778653478 @default.
• W4230752000 hasConcept C2779379848 @default.
• W4230752000 hasConcept C2780303639 @default.
• W4230752000 hasConcept C2908647359 @default.
• W4230752000 hasConcept C2911091166 @default.
• W4230752000 hasConcept C44249647 @default.
• W4230752000 hasConcept C71924100 @default.
• W4230752000 hasConcept C82789193 @default.

• next